OPA1 mutations in dominant optic atrophy: domain-specific defects in mitochondrial fusion and apoptotic regulation

Abstract Background Autosomal dominant optic atrophy (ADOA), a leading common inherited optic neuropathy, arises from progressive retinal ganglion cell degeneration, often linked to OPA1 mutations. OPA1, a mitochondrial GTPase, regulates mitochondrial fusion, crista structure, and apoptosis. While G...

Full description

Saved in:
Bibliographic Details
Main Authors: Kexuan Zhang, Wenqing Zhang, Lin Zhang, Xiaorong Hou, Runyi Tian, Zhengmao Hu, Lili Yin, Zhonghua Hu
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-025-06471-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850172727506239488
author Kexuan Zhang
Wenqing Zhang
Lin Zhang
Xiaorong Hou
Runyi Tian
Zhengmao Hu
Lili Yin
Zhonghua Hu
author_facet Kexuan Zhang
Wenqing Zhang
Lin Zhang
Xiaorong Hou
Runyi Tian
Zhengmao Hu
Lili Yin
Zhonghua Hu
author_sort Kexuan Zhang
collection DOAJ
description Abstract Background Autosomal dominant optic atrophy (ADOA), a leading common inherited optic neuropathy, arises from progressive retinal ganglion cell degeneration, often linked to OPA1 mutations. OPA1, a mitochondrial GTPase, regulates mitochondrial fusion, crista structure, and apoptosis. While GTPase-related dysfunction is well-studied, the role of other OPA1 domains in ADOA pathology remains unclear. Methods To investigate ADOA-linked OPA1 mutations, we assessed mitochondrial morphology, membrane potential, cytochrome c release, and cell viability in primary cortical neurons and N2a cells expressing OPA1 wild-type or mutant constructs. RNA sequencing and structural predictions (SWISS-MODEL) provided insights into molecular pathways and structural impacts. Results Two ADOA-associated mutations were characterized: V465F (GTPase β-fold) and V560F (BSE α-helix). Both mutations impaired mitochondrial fusion and cell survival under apoptotic stimuli. Notably, the BSE-located V560F mutation caused greater deficits in membrane potential maintenance, earlier apoptosis, and distinct molecular pathway changes compared to V465F. Conclusions This study highlights the domain-specific impacts of OPA1 mutations on mitochondrial function and ADOA pathology, revealing unique roles of the BSE domain in apoptosis regulation and mitochondrial integrity. These findings provide insights into ADOA mechanisms and potential therapeutic targets.
format Article
id doaj-art-911eb7eb10d147b3a713c7e84e2b1ab1
institution OA Journals
issn 1479-5876
language English
publishDate 2025-04-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj-art-911eb7eb10d147b3a713c7e84e2b1ab12025-08-20T02:20:01ZengBMCJournal of Translational Medicine1479-58762025-04-0123112010.1186/s12967-025-06471-wOPA1 mutations in dominant optic atrophy: domain-specific defects in mitochondrial fusion and apoptotic regulationKexuan Zhang0Wenqing Zhang1Lin Zhang2Xiaorong Hou3Runyi Tian4Zhengmao Hu5Lili Yin6Zhonghua Hu7Department of Critical Care Medicine, Institute of Molecular Precision Medicine and Hunan Key Laboratory of Molecular Precision Medicine, Xiangya Hospital, Central South UniversityDepartment of Critical Care Medicine, Institute of Molecular Precision Medicine and Hunan Key Laboratory of Molecular Precision Medicine, Xiangya Hospital, Central South UniversityDepartment of Critical Care Medicine, Institute of Molecular Precision Medicine and Hunan Key Laboratory of Molecular Precision Medicine, Xiangya Hospital, Central South UniversityDepartment of Neurology, The Third Xiangya Hospital, Central South UniversityCenter for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South UniversityCenter for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South UniversityDepartment of Ophthalmology, Shanghai Fourth People’s Hospital, Tongji UniversityDepartment of Critical Care Medicine, Institute of Molecular Precision Medicine and Hunan Key Laboratory of Molecular Precision Medicine, Xiangya Hospital, Central South UniversityAbstract Background Autosomal dominant optic atrophy (ADOA), a leading common inherited optic neuropathy, arises from progressive retinal ganglion cell degeneration, often linked to OPA1 mutations. OPA1, a mitochondrial GTPase, regulates mitochondrial fusion, crista structure, and apoptosis. While GTPase-related dysfunction is well-studied, the role of other OPA1 domains in ADOA pathology remains unclear. Methods To investigate ADOA-linked OPA1 mutations, we assessed mitochondrial morphology, membrane potential, cytochrome c release, and cell viability in primary cortical neurons and N2a cells expressing OPA1 wild-type or mutant constructs. RNA sequencing and structural predictions (SWISS-MODEL) provided insights into molecular pathways and structural impacts. Results Two ADOA-associated mutations were characterized: V465F (GTPase β-fold) and V560F (BSE α-helix). Both mutations impaired mitochondrial fusion and cell survival under apoptotic stimuli. Notably, the BSE-located V560F mutation caused greater deficits in membrane potential maintenance, earlier apoptosis, and distinct molecular pathway changes compared to V465F. Conclusions This study highlights the domain-specific impacts of OPA1 mutations on mitochondrial function and ADOA pathology, revealing unique roles of the BSE domain in apoptosis regulation and mitochondrial integrity. These findings provide insights into ADOA mechanisms and potential therapeutic targets.https://doi.org/10.1186/s12967-025-06471-wAutosomal dominant optic atrophy (ADOA)OPA1 mutationsMitochondrial dynamicsApoptosisGTPase activityBundle signaling element (BSE)
spellingShingle Kexuan Zhang
Wenqing Zhang
Lin Zhang
Xiaorong Hou
Runyi Tian
Zhengmao Hu
Lili Yin
Zhonghua Hu
OPA1 mutations in dominant optic atrophy: domain-specific defects in mitochondrial fusion and apoptotic regulation
Journal of Translational Medicine
Autosomal dominant optic atrophy (ADOA)
OPA1 mutations
Mitochondrial dynamics
Apoptosis
GTPase activity
Bundle signaling element (BSE)
title OPA1 mutations in dominant optic atrophy: domain-specific defects in mitochondrial fusion and apoptotic regulation
title_full OPA1 mutations in dominant optic atrophy: domain-specific defects in mitochondrial fusion and apoptotic regulation
title_fullStr OPA1 mutations in dominant optic atrophy: domain-specific defects in mitochondrial fusion and apoptotic regulation
title_full_unstemmed OPA1 mutations in dominant optic atrophy: domain-specific defects in mitochondrial fusion and apoptotic regulation
title_short OPA1 mutations in dominant optic atrophy: domain-specific defects in mitochondrial fusion and apoptotic regulation
title_sort opa1 mutations in dominant optic atrophy domain specific defects in mitochondrial fusion and apoptotic regulation
topic Autosomal dominant optic atrophy (ADOA)
OPA1 mutations
Mitochondrial dynamics
Apoptosis
GTPase activity
Bundle signaling element (BSE)
url https://doi.org/10.1186/s12967-025-06471-w
work_keys_str_mv AT kexuanzhang opa1mutationsindominantopticatrophydomainspecificdefectsinmitochondrialfusionandapoptoticregulation
AT wenqingzhang opa1mutationsindominantopticatrophydomainspecificdefectsinmitochondrialfusionandapoptoticregulation
AT linzhang opa1mutationsindominantopticatrophydomainspecificdefectsinmitochondrialfusionandapoptoticregulation
AT xiaoronghou opa1mutationsindominantopticatrophydomainspecificdefectsinmitochondrialfusionandapoptoticregulation
AT runyitian opa1mutationsindominantopticatrophydomainspecificdefectsinmitochondrialfusionandapoptoticregulation
AT zhengmaohu opa1mutationsindominantopticatrophydomainspecificdefectsinmitochondrialfusionandapoptoticregulation
AT liliyin opa1mutationsindominantopticatrophydomainspecificdefectsinmitochondrialfusionandapoptoticregulation
AT zhonghuahu opa1mutationsindominantopticatrophydomainspecificdefectsinmitochondrialfusionandapoptoticregulation